Who we are
Corticalis AS was founded in 2006 by leading researchers and clinicians with extensive experience developing and marketing dental implants and regenerative therapies. The company aims to develop its own innovative and sustainable medical devices for professional follow-up of patients treated for oral diseases and wounds on the skin and mucous membranes.
Corticalis places particular emphasis on creating and promoting alternatives to antibiotic-based antimicrobial agents. The increased use of antibiotics is causing bacteria and other microbes to become resistant to medication. Corticalis offers effective alternatives to antibiotics so that this problem can be avoided.
Today, the company has finished products for maintaining teeth and dental implants that are prone to gum disease. These products, developed with a focus on patient comfort and effectiveness, offer a comprehensive solution for oral health. Corticalis has also developed a nature-mimicking, non-animal product for surgically rebuilding supportive tissue around teeth and implants where it has been lost due to disease. These products will be marketed through a global network of established distributors.
During its development phase, Corticalis has undergone evaluations and received significant support from the Research Council of Norway and the European Union. The company has three times been awarded the European Commission’s “Seal of Excellence,” an essential confirmation of its projects and products' high quality and societal value.
Our Mission
We aim to develop evidence-based, nature-inspired, and antibiotic-free solutions to provide safe, effective, and sustainable PeriHealth® maintenance, implant support and wound care.

-
Antibiotic-Free Implant Care
Eliminating antibiotics in implant care, addressing the growing issue of microbial resistance, and minimizing the risk of complicated infections.
Staff

Ståle Petter Lyngstadaas
Prof., DDS, PhD, BEng
Founder and dentist with background in molecular biology and biomaterials. As Managing Director, Lyngstadaas oversees Corticalis’ strategic direction and daily operations. He ensures cross-functional collaboration to drive the company’s vision and maintain sustainable growth. R&D Experience from the biotech industry.

Jan Eirik Ellingsen
Prof., DDS, PhD
Founder, dentist and specialist in prosthodontics and implantology. Ellingsen leads the board and oversees clinical research, drawing on his extensive experience to guide Corticalis’ commitment to evidence-based, patient-focused innovation. Experience in implant product commercialisation.
Clinical Advisory Board

Morten Klepp
DDS, MSc
A highly qualified periodontist at Colosseum Tannlege Solakrossen, specialising in advanced periodontal treatment and implantology. Educated at the University of Minnesota and the University of Oslo, he offers expert care for periodontal diseases, implant placement, and long-term oral health maintenance.

Lisa Heitz-Mayfield
DDS, PhD
Adjunct Professor at the University of Western Australia and the University of Sydney. Dr Heitz-Mayfield also runs a specialist periodontal practice in Perth, combining extensive academic expertise with clinical care. She additionally serves as Editor-in-Chief of Clinical Oral Implants Research.

Leonardo Trombelli
DDS, PhD
Professor and Head of Periodontology at the University of Ferrara. With extensive expertise in periodontal regeneration, soft-tissue treatment, and peri-implant health, he has been instrumental in advancing clinical and translational research in these areas.
Board

Jan Eirik Ellingsen
Chairman
Founder, dentist and specialist in prosthodontics and implantology. Ellingsen leads the board and oversees clinical research, drawing on his extensive experience to guide Corticalis’ commitment to evidence-based, patient-focused innovation. Experience in implant product commercialisation.

Ståle Petter Lyngstadaas
Board member
Founder and dentist with background in molecular biology and biomaterials. As Managing Director, Lyngstadaas oversees Corticalis’ strategic direction and daily operations. He ensures cross-functional collaboration to drive the company’s vision and maintain sustainable growth. R&D Experience from the biotech industry.
Our collaboration Partners